Log in to search using one of your social media accounts:

 

Liposarcoma Symptoms and Treatment
Title: Liposarcoma Symptoms and TreatmentCategory: Doctor's& Expert's views on SymptomsCreated: 9/24/2014 12:00:00 AMLast Editorial Review: 4/7/2017 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - April 7, 2017 Category: Cancer & Oncology Source Type: news

Aldoxorubicin Improves PFS in Some Relapsed/Refractory Sarcomas
Aldoxorubicin yielded significantly better progression-free survival over investigator ’s choice of various chemotherapy options in patients with relapsed or refractory leiomyosarcoma and liposarcoma, according to updated results of a phase III trial. (Source: CancerNetwork)
Source: CancerNetwork - December 30, 2016 Category: Cancer & Oncology Authors: Dave Levitan Tags: News Sarcoma Source Type: news

New Cancer Drug Approvals From 2016
Chemotherapy is one of the most powerful tools we have to treat cancer, and research continues to find new chemotherapy drugs as well as new uses for existing ones. At the same time, newer types of drugs are continually being developed that work in different ways to attack cancer cells.They include targeted therapy, which aims to more precisely identify cancer cells while doing less damage to normal cells, and immunotherapy, which uses the body’s own immune system to help find and destroy cancer.Before any new drug can be sold in the United States, it has to go through an approval process by the Food and Drug Adminis...
Source: American Cancer Society :: News and Features - December 26, 2016 Category: Cancer & Oncology Tags: Advanced Cancer Source Type: news

Eribulin in liposarcoma: Added benefit not proven
(Institute for Quality and Efficiency in Health Care) Neither the results from a study of direct comparison nor from an indirect comparison were suitable for the assessment. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 7, 2016 Category: Global & Universal Source Type: news

Eisai Bewildered as German Institute for Quality and Efficiency in Health Care (IQWIG) Fails to Recognise Additional Benefit of Halaven(R) (eribulin) in the Treatment of Advanced Liposarcoma
Assessment ignores unprecedented overall survival benefit for eribulin in advanced liposarcoma[1] HATFIELD, England, September 4, 2016 -- (Healthcare Sales & Marketing Network) -- The German Institute for Quality and Efficiency in Health Care (IQWiG) h... Biopharmaceuticals, Oncology, Regulatory Eisai, Halaven, eribulin, Liposarcoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 5, 2016 Category: Pharmaceuticals Source Type: news

Former Toronto Mayor Rob Ford's Rare Abdominal Cancer, Explained
Rob Ford, the controversial former Toronto mayor who was known both for smoking crack cocaine in office and his intense popularity among conservative working-class voters, died today at the age of 46. The cause of death was not announced, but Ford was being treated for rare abdominal cancer called pleomorphic liposarcoma -- a diagnosis he received in 2014.  "It's rare to have a highly successful outcome with a pleomorphic liposarcoma once it's spread," Dr. Brian Van Tine, a medical oncologist at Washington University in St. Louis, told the Canadian Press.  Liposarcomas belong to a class of tumors t...
Source: Science - The Huffington Post - March 22, 2016 Category: Science Source Type: news

Former Toronto Mayor Rob Ford's Rare Abdominal Cancer, Explained
Rob Ford, the controversial former Toronto mayor who was known both for smoking crack cocaine in office and his intense popularity among conservative working-class voters, died today at the age of 46. The cause of death was not announced, but Ford was being treated for rare abdominal cancer called pleomorphic liposarcoma -- a diagnosis he received in 2014.  "It's rare to have a highly successful outcome with a pleomorphic liposarcoma once it's spread," Dr. Brian Van Tine, a medical oncologist at Washington University in St. Louis, told the Canadian Press.  Liposarcomas belong to a class of tumors t...
Source: Healthy Living - The Huffington Post - March 22, 2016 Category: Consumer Health News Source Type: news

Rob Ford died suffering from pleomorphic liposarcoma
Former Toronto Mayor Rob Ford died Tuesday while suffering from a rare type of cancer known as pleomorphic liposarcoma. (Source: CBC | Health)
Source: CBC | Health - March 22, 2016 Category: Consumer Health News Tags: News/Canada/Toronto Source Type: news

Halaven (eribulin mesylate) for the Treatment of Advanced Liposarcoma
Halaven (eribulin mesylate) is an injectable chemotherapy drug developed by Eisai for the treatment of unresectable or metastatic liposarcoma patients that previously received anthracycline-based chemotherapy. (Source: Drug Development Technology)
Source: Drug Development Technology - February 11, 2016 Category: Pharmaceuticals Source Type: news

Eisai’s Halaven Injection gets FDA approval to treat advanced liposarcoma
The US Food and Drug Administration (FDA) has granted approval for Eisai's Halaven (eribulin mesylate) Injection (0.5mg/mL) to treat patients with unresectable or metastatic liposarcoma who have received a prior anthracycline-containing regimen. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - February 1, 2016 Category: Pharmaceuticals Source Type: news

D.C. Week: Senator Places Hold on Califf's FDA Nomination
(MedPage Today) -- Breast cancer drug gains approval for liposarcoma (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - January 30, 2016 Category: Psychiatry Source Type: news

FDA Approves Halaven (Eribulin) for Liposarcoma
By Stacy SimonThe US Food and Drug Administration (FDA) has approved the chemotherapy drug Halaven (eribulin) to treat liposarcoma, a type of soft tissue sarcoma. Halaven is already approved to treat advanced breast cancer. The new use is for people with liposarcoma who have already been treated with anthracycline-based chemotherapy and have tumors that cannot be removed through surgery or have spread to other parts of the body. This is the first drug approved for people with liposarcoma that has shown improvement in overall survival.Liposarcomas are cancerous tumors of fat tissue. They can develop anywhere in the body, bu...
Source: American Cancer Society :: News and Features - January 30, 2016 Category: Cancer & Oncology Tags: Sarcoma - Adult Soft Tissue Cancer Source Type: news

FDA Approves Eisai's Halaven(R) (eribulin mesylate) Injection for the Treatment of Patients with Advanced Liposarcoma
Halaven is the first and only single agent to prolong overall survival in patients with previously treated advanced (unresectable or metastatic) liposarcoma in a Phase 3 trial With these pivotal data, Halaven is twice-proven to give more time to patient... Biopharmaceuticals, Oncology, FDAEisai, Halaven, eribulin, Liposarcoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 29, 2016 Category: Pharmaceuticals Source Type: news

Halaven Approved for Advanced Soft Tissue Cancer
FDA says it's first liposarcoma drug to improve survival (Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - January 29, 2016 Category: Cancer & Oncology Source Type: news

Halaven Approved for Advanced Soft Tissue Cancer
FDA says it's first liposarcoma drug to improve survival (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - January 28, 2016 Category: Cancer & Oncology Authors: webmaster at doctorslounge.com Tags: Oncology, Pharmacy, FDA Approvals, Source Type: news

FDA Approves Halaven (eribulin mesylate) for the Treatment of Liposarcoma
January 28, 2016 -- The U.S. Food and Drug Administration today approved Halaven (eribulin mesylate), a type of chemotherapy, for the treatment of liposarcoma (a specific type of soft tissue sarcoma) that cannot be removed by surgery (unresectable)... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - January 28, 2016 Category: Drugs & Pharmacology Source Type: news

Eribulin Approved for Liposarcoma, Improves SurvivalEribulin Approved for Liposarcoma, Improves Survival
Already approved for use in breast cancer, eribulin is the first drug to show an improved overall survival in patients with liposarcoma. News Alerts (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 28, 2016 Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news

Breast Cancer Drug OK'd for Liposarcoma
(MedPage Today) -- Halaven is first agent to demonstrate survival benefit in rare cancer (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - January 28, 2016 Category: Primary Care Source Type: news

FDA approves first drug to show survival benefit in liposarcoma
The U.S. Food and Drug Administration today approved Halaven (eribulin mesylate), a type of chemotherapy, for the treatment of liposarcoma (a specific type of soft tissue sarcoma) that cannot be removed by surgery (unresectable) or is advanced (metastatic). This treatment is approved for patients who received prior chemotherapy that contained an anthracycline drug. (Source: Food and Drug Administration)
Source: Food and Drug Administration - January 28, 2016 Category: American Health Source Type: news

FDA approves first drug to show survival benefit in liposarcoma
The U.S. Food and Drug Administration today approved Halaven (eribulin mesylate), a type of chemotherapy, for the treatment of liposarcoma (a specific type of soft tissue sarcoma) that cannot be removed by surgery (unresectable) or is advanced (metastatic). (Source: World Pharma News)
Source: World Pharma News - January 28, 2016 Category: Pharmaceuticals Tags: Featured Food and Drug Administration (FDA) Regulatory Affairs Source Type: news

October's top stories: Clinical trial to test aspirin, treatment for liposarcoma
FDA grants breakthrough status for Pfizer's leukaemia drug inotuzumab ozogamicin, Alkermes's Aristada gets FDA approval to treat schizophrenia, Domainex and Imperial to discover new therapies for myocardial infarction. Pharmaceutical-technology.com w… (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - November 9, 2015 Category: Pharmaceuticals Source Type: news

Janssen's Yondelis gets FDA approval to treat unresectable or metastatic LPS or LMS
Janssen Biotech has received approval from the US Food and Drug Administration (FDA) for Yondelis (trabectedin) to treat patients with unresectable or metastatic liposarcoma (LPS) or leiomyosarcoma (LMS) who received a prior anthracycline-containing … (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 26, 2015 Category: Pharmaceuticals Source Type: news

FDA approves new therapy for certain types of advanced soft tissue sarcoma
The U.S. Food and Drug Administration today approved Yondelis (trabectedin), a chemotherapy, for the treatment of specific soft tissue sarcomas (STS) – liposarcoma and leiomyosarcoma – that cannot be removed by surgery (unresectable) or is advanced (metastatic). This treatment is approved for patients who previously received chemotherapy that contained anthracycline. (Source: Food and Drug Administration)
Source: Food and Drug Administration - October 23, 2015 Category: American Health Source Type: news

Pregnant Tamworth woman's life is saved thanks to a CAR CRASH
Michelle Cartwright, 32, from Tamworth, discovered she was suffering the rare cancer, liposarcoma, when medics X-rayed her leg following a minor car crash. (Source: the Mail online | Health)
Source: the Mail online | Health - June 8, 2015 Category: Consumer Health News Source Type: news

Stuart Brookes whose cancer was mistaken for a pulled MUSCLE given 18 months to live
Stuart Brookes, 30, from Birmingham, is battling metastasis myxoid liposarcoma for a second time and is trying to raise £150,000 to travel to the US for treatment after he was given 18 months to live. (Source: the Mail online | Health)
Source: the Mail online | Health - February 18, 2015 Category: Consumer Health News Source Type: news

Liposarcoma Information: Symptoms and Treatment
Liposarcoma is a malignant tumor that arises in fat cells in deep soft tissue, such as that inside the thigh or in the retroperitoneum. It is most commonly found in your legs or thighs, but it can also be found in your abdomen, back, arms, chest, and neck. (Source: Disabled World)
Source: Disabled World - January 5, 2015 Category: Disability Tags: Cancer and Tumors Source Type: news

Cancer Patients Growing Their Own Tumors In Mice In Hopes Of A Cure
Scientists often test drugs in mice. Now some cancer patients are doing the same - with the hope of curing their own disease. They are paying a private lab to breed mice that carry bits of their own tumors so treatments can be tried first on the customized rodents. The idea is to see which drugs might work best on a specific person's specific cancer. The mice may help patients make what can be very hard choices under difficult circumstances. Studies can suggest a certain chemotherapy may help, but patients wonder whether it will work for them. Often there's more than one choice, and if the first one fails, a patient may ...
Source: Science - The Huffington Post - December 15, 2014 Category: Science Source Type: news

PharmaMar announces US partner Janssen files NDA for YONDELIS for soft-tissue sarcoma
(Pharmamar) Based on a phase 3 trial in which dacarbazine was used in the comparator arm, Janssen has submitted a NDA for YONDELIS (trabectedin) to the FDA for the treatment of patients with advanced soft tissue sarcoma, including liposarcoma and leiomyosarcoma, who have received prior chemotherapy including an anthracycline. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 25, 2014 Category: Cancer & Oncology Source Type: news

Liposarcoma Symptoms and Treatment
Title: Liposarcoma Symptoms and TreatmentCategory: Doctor's & Expert's views on SymptomsCreated: 9/24/2014 1:07:00 PMLast Editorial Review: 9/24/2014 1:07:07 PM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - September 24, 2014 Category: Cancer & Oncology Source Type: news

New York doctors save patient with 20-pound tumor
Doctors at NYU Langone Medical Center saved a man with a liposarcoma, a rare cancer. The patient had a 20-pound tumor and didn’t even know it. Craig Boswell reports this story from Staten Island, New York. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - August 22, 2014 Category: Consumer Health News Source Type: news

Unusual Case of a 20 Pound Tumor Unusual Case of a 20 Pound Tumor
An unusually large tumor, of which the patient was unaware, turned out to be a liposarcoma also containing some bone and cartilage tissue. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 17, 2014 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

[Podcast] Science Signaling Podcast: 24 September 2013
Drug screening and network modeling suggest a combination therapy for liposarcoma. (Source: Signal Transduction Knowledge Environment)
Source: Signal Transduction Knowledge Environment - September 27, 2013 Category: Science Authors: Martin L. Miller, Chris Sander, Annalisa M. VanHook Source Type: news

[Research Article] Drug Synergy Screen and Network Modeling in Dedifferentiated Liposarcoma Identifies CDK4 and IGF1R as Synergistic Drug Targets
Drug screening and computational modeling of oncogenic signaling pathways identifies synergistic drug pairs for liposarcoma. (Source: Signal Transduction Knowledge Environment)
Source: Signal Transduction Knowledge Environment - September 27, 2013 Category: Science Authors: Martin L. Miller, Evan J. Molinelli, Jayasree S. Nair, Tahir Sheikh, Rita Samy, Xiaohong Jing, Qin He, Anil Korkut, Aimee M. Crago, Samuel Singer, Gary K. Schwartz, Chris Sander Source Type: news